Latest Board And Leadership News

Steadfast Group announces the planned retirement of co-founder and CEO Robert Kelly AM, initiating a structured leadership transition with a new CEO expected by August 2026.

ION Video Ltd has strengthened its board with the return of its original inventor, Finbar O’Hanlon, alongside CEO Anthony Baker, as the company pivots to become foundational infrastructure for Video Superintelligence.

Merino & Co. reported steady progress in Q2 FY26 with growing demand from China and ongoing investments in brand and manufacturing, despite a tightening cash position.

Iondrive Limited has marked a pivotal shift from development to commercialisation of its IONSolv™ technology, securing $4 million to target the US e-waste market and commissioning its pilot plant to refine critical minerals.

Castle Minerals has advanced its West African gold exploration with extensive soil sampling and auger drilling, while strengthening its board and maintaining a solid cash position of approximately A$3 million.

Temas Resources has appointed Nic Matich as a Non-Executive Director to spearhead Australian investor relations and business development, while CFO David Robinson transitions to a full-time executive role to sharpen financial oversight amid the company’s growth and commercialisation push.

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.

Pinnacle Minerals announces a strategic leadership reshuffle, appointing William Witham as Managing Director and CEO, Stephen Ross as Non-Executive Chairman, and welcoming Jay Stephenson to the board.

Altech Batteries Limited has undergone a significant board and management reshuffle following a shareholder-led challenge, appointing new leadership while reaffirming its strategic focus on advanced battery technologies.

GenusPlus Group has reported a landmark FY2025 with record revenue and profits, driven by strong growth in renewable energy infrastructure and transmission projects. The company’s robust orderbook and strategic acquisitions set the stage for continued expansion in FY2026.

Senetas Corporation Limited successfully passed all resolutions at its 2025 Annual General Meeting, including director re-elections, executive option grants, and a capital return proposal.

Invex Therapeutics has appointed two new non-executive directors and joint company secretaries, signaling a refreshed governance structure alongside a change of company address.